Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.

ABSTRACT:

SUBMITTER: Kumar Rai G 

PROVIDER: S-EPMC8942857 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature